GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (MEX:PRQR) » Definitions » Common Stock

ProQR Therapeutics NV (MEX:PRQR) Common Stock : MXN94.1 Mil (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is ProQR Therapeutics NV Common Stock?

ProQR Therapeutics NV's quarterly common stock increased from Jun. 2024 (MXN66.5 Mil) to Sep. 2024 (MXN73.6 Mil) and increased from Sep. 2024 (MXN73.6 Mil) to Dec. 2024 (MXN94.1 Mil).

ProQR Therapeutics NV's annual common stock declined from Dec. 2022 (MXN69.6 Mil) to Dec. 2023 (MXN62.4 Mil) but then increased from Dec. 2023 (MXN62.4 Mil) to Dec. 2024 (MXN94.1 Mil).


ProQR Therapeutics NV Common Stock Historical Data

The historical data trend for ProQR Therapeutics NV's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Common Stock Chart

ProQR Therapeutics NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 52.39 69.42 69.60 62.38 94.08

ProQR Therapeutics NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.38 60.79 66.46 73.65 94.08

ProQR Therapeutics NV Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


ProQR Therapeutics NV Business Description

Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.